The Situation
- Global specialty pharmaceutical and medication delivery company with large US based footprint
- Specialty injectable pharmaceuticals and medication management systems are primary growth drivers
- Client is currently 3rd quartile share price performer
- Management has top quartile total shareholder returns aspirations, and engaged Bain to do performance improvement and transformation effort
Our Approach
Significantly reduce product line complexity:
Our Recommendations
Adhere to five principles to prevent complexity from re-entering the system:
The Results
Margin improvement by reducing number of products:
* We take our clients' confidentiality seriously. While we've changed their names, the results are real.
